Hyperbaric oxygen therapy (HBOT)

by Artisan

OUR services

Hyperbaric oxygen therapy (HBOT)

What is HBOT?
13 conditions for which hyperbaric chambers are cleared for marketing by the FDA
See reference:
Conditions for which hyperbaric chambers are cleared for marketing by the FDA
See reference:
Huang X, Liang P, Jiang B, Zhang P, Yu W, Duan M, Guo L, Cui X, Huang M, Huang X.
See reference:
Jeffrey S. Cooper; Mary E. Hanley; Stephen Hendriksen; Marc Robins.
Emerging / Off-Label / Investigational Uses of HBOT

Long COVID / Post-COVID Syndrome

HBOT has been shown to help individuals experiencing prolonged post-COVID symptoms, including fatigue, cognitive dysfunction (“brain fog”), and breathlessness. It reduces systemic inflammation and improves oxygenation, especially in underperfused areas of the brain and lungs.

Hyperbaric oxygen therapy (HBOT) at Artisan Regenerative Centre
Why people love HBOT
HBOT Clinical Trials
The effect of hyperbaric oxygen therapy on the pathophysiology of skin aging: a prospective clinical trial
Yafit Hachmo1,*, Amir Hadanny2,3,4,*, Sonia Mendelovic5, Pnina Hillman5, Eyal Shapira6,
Geva Landau6, Hadar Gattegno1, Avi Zrachya1, Malka Daniel-Kotovsky2, Merav Catalogna2,
Gregory Fishlev2, Erez Lang2, Nir Polak2, Keren Doenyas2, Mony Friedman2, Yonatan Zemel2,
Yair Bechor2, Shai Efrati1,2,3,7  
Published in AGING 2021, Vol. 13, No, 22
Figure 1. Elastic fiber changes. Following HBOT, there was a significant increase in elastic fiber numbers, along with a significant decrease in their fragmentation.

Figure 2. Papillary layer thickness changes. Following HBOT, there was a significant decrease in the papillary layer thickness.

Figure 3. Blood vessels changes. Following HBOT, there was a significant increase in tissue blood vessels. Left column: DAPI staining for intact cells evaluation, middle column: CD31 staining of endothelial cells; right column: merging of DAPI and CD31.

Figure 4. Senescence cells changes. Following HBOT, there was a significant decrease in number of tissue senescent cells.

This study presents a research study evaluating the effects of hyperbaric oxygen therapy on skin aging in a normal aging population through skin biopsies and various physiological assessments.

Key Findings on Skin Aging 13​

The study revealed significant histological changes in the skin of participants after HBOT, indicating its potential to reverse some aging effects. 14

  • No changes in elastic fiber density or thickness were noted, but fragmentation decreased significantly (90% high fragmentation to 10% post-HBOT). 15
  • Collagen fiber density increased significantly from 67.84±10.98% at baseline to 76.61±9.52% post-HBOT.
  • Papillary layer thickness decreased significantly from 133.22±22.42 μm to 106.60±31.01 μm after HBOT.
  • The number of blood vessels increased from 24.00±15.72 to 33.40±12.28 post-HBOT. 17

Mechanisms of Action

The study suggests that HBOT may exert its effects through mechanisms such as angiogenesis and clearance of senescent cells, which are critical in the aging process. 18

  • HBOT induced angiogenesis, evidenced by increased CD31 intensity (625.81±394.29 post-HBOT). 19
  • The number of senescent cells decreased significantly from 3.14±1.06 to 2.48±1.23 after HBOT. 7
  • The study highlights the role of hypoxic-induced factors (HIFs) in promoting angiogenesis through HBOT. 20

Conclusion

Therefore, in this study, Hyperbaric oxygen therapy (HBOT) has been shown to significantly improve skin aging in a healthy aging population by enhancing collagen density, elastic fiber length, and reducing aged, senescent skin cells.


This study is the first to demonstrate these effects in humans, indicating potential therapeutic benefits of HBOT for skin aging.

Physical enhancement of older adults using hyperbaric oxygen: a randomized controlled trial

This paper reports on a randomized controlled trial evaluating the effects of hyperbaric oxygen therapy on physical performance and cardiac perfusion in sedentary older adults.

Effects of Hyperbaric Oxygen Therapy on Aging

The study investigates the impact of hyperbaric oxygen therapy (HBOT) on physical performance and cardiac function in sedentary older adults. Results indicate significant improvements in oxygen consumption and cardiac perfusion following HBOT.

Study Design and Methodology

A randomized controlled trial conducted from 2016 to 2020.
Involved 63 adults aged 64 and older, divided into HBOT (n=30) and control (n=33) groups.
Participants underwent 60 sessions of HBOT over 12 weeks, breathing 100% oxygen at 2 ATA for 90 minutes.
Primary endpoints included VO2Max and VO2Max/kg; secondary endpoints included cardiac perfusion and pulmonary function.

Key Findings on Physical Performance

Significant increase in VO2Max/kg by 1.91 ± 3.29 ml/kg/min (p = 0.0034) with a net effect size of 0.455.

VO2 consumption at the first ventilatory threshold (VO2VT1) increased by 160.03 ± 155.35 ml/min (p < 0.001) with a net effect size of 0.617.

Cardiac Perfusion Improvements

Global myocardial blood flow (MBF) increased from 0.34 ± 0.10 to 0.42 ± 0.19 ml/100 g/min (p = 0.008), with a large effect size of 0.797.

Global myocardial blood volume (MBV) increased from 0.53 ± 0.14 to 0.61 ± 0.22 ml/100 g (p = 0.009), with an effect size of 0.896.

Moderate correlations observed between MBV changes and VO2Max (r = 0.45, p = 0.043).

Enhancements in Physical Performance with HBOT

The study demonstrates that Hyperbaric Oxygen Therapy (HBOT) significantly improves physical performance metrics in elderly individuals, particularly in VO2Max and cardiac perfusion. These enhancements are crucial for maintaining an independent lifestyle in older adults.

VO2Max, VO2Max/Kg, and VO2VT1 significantly increased in the HBOT group compared to the control group.
The HBOT group exhibited improved general cardiac perfusion, measured by Myocardial Blood Flow (MBF) and Myocardial Blood Volume (MBV).

The elderly rely heavily on VO2Max for daily tasks, making these improvements particularly relevant.

Participant Characteristics and Demographics

The study involved a total of 63 participants, divided into control and HBOT groups, with a focus on their health and demographic characteristics.

Average age of participants was 69.70 years, with 61.9% being male.
36.5% had a history of orthopedic surgery, and 47.6% had dyslipidemia.
Chronic conditions included hypertension (22%), diabetes mellitus (15.9%), and atrial fibrillation (6.3%).

Baseline Measurements and Comparisons

Baseline measurements were taken to assess the initial health status of participants before the intervention.
Height, weight, BMI, and body surface area (BSA) were similar across groups, with no significant differences.

VO2Max was recorded at 1514.62 ± 521.17 mL/min, with no significant difference between groups.

VO2Max/Kg was 19.73 ± 5.93 mL/kg/min, also showing no significant differences.

Changes in Cardiopulmonary Exercise Testing (CPET)

The study evaluated changes in CPET parameters to assess the impact of HBOT on physical performance.
VO2Max increased significantly in the HBOT group (1517.98 ± 488.42 mL/min) compared to the control group (1584.70 ± 493.87 mL/min).

VO2VT1 showed a significant increase in the HBOT group (927.57 ± 308.28 mL/min) compared to baseline.

Power output and other secondary endpoints showed no significant changes.

Cardiac Perfusion Improvements with HBOT

The study highlights the effects of HBOT on cardiac perfusion, indicating potential benefits for heart health in elderly individuals.
MBF increased significantly in the HBOT group (0.30 ± 0.08) compared to baseline (0.34 ± 0.10).
MBV also showed significant improvement in the HBOT group (0.46 ± 0.12) compared to baseline (0.53 ± 0.14).
These changes suggest enhanced cardiac microcirculation due to HBOT.

The study's design allows for the isolation of HBOT effects, supporting the validity of the findings.

Conclusion on HBOT's Impact on Elderly Performance

The findings suggest that HBOT can significantly enhance physical performance in aging adults, particularly in terms of oxygen consumption and cardiac function.
The study indicates that combining HBOT with physical training may yield synergistic effects, warranting further investigation.
The results underscore the potential of HBOT as a therapeutic intervention for improving quality of life in the elderly.

Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients – a retrospective analysis

Background

Previous studies have shown that hyperbaric oxygen therapy (HBOT) can improve the motor functions and memory of post-stroke patients in the chronic stage.

Objective

The aim of this study is to evaluate the effects of HBOT on overall cognitive functions of post-stroke patients in the chronic stage. The nature, type and location of the stroke were investigated as possible modifiers.

Methods

A retrospective analysis was conducted on patients who were treated with HBOT for chronic stroke (>3 months) between 2008-2018. Participants were treated in a multi-place hyperbaric chamber with the following protocols: 40 to 60 daily sessions, 5 days per week, each session included 90 min of 100% oxygen at 2 ATA with 5 min air brakes every 20 minutes. Clinically significant improvements (CSI) were defined as > 0.5 standard deviation (SD).

Results

The study included 162 patients (75.3% males) with a mean age of 60.75 ± 12.91. Of them, 77(47.53%) had cortical strokes, 87(53.7%) strokes were located in the left hemisphere and 121 suffered ischemic strokes (74.6%). HBOT induced a significant increase in all the cognitive function domains (p < 0.05), with 86% of the stroke victims achieving CSI. There were no significant differences post-HBOT of cortical strokes compared to sub-cortical strokes (p > 0.05). Hemorrhagic strokes had a significantly higher improvement in information processing speed post-HBOT (p < 0.05). Left hemisphere strokes had a higher increase in the motor domain (p < 0.05). In all cognitive domains, the baseline cognitive function was a significant predictor of CSI (p < 0.05), while stroke type, location and side were not significant predictors.

Conclusions

HBOT induces significant improvements in all cognitive domains even in the late chronic stage. The selection of post-stroke patients for HBOT should be based on functional analysis and baseline cognitive scores rather than the stroke type, location or side of lesion.

The use of hyperbaric oxygen for avascular necrosis of the femoral head and femoral condyle: a single centre’s experience over 30 years

This document discusses a 30-year experience with hyperbaric oxygen treatment for avascular necrosis of the femoral head and condyle.

Introduction

Avascular necrosis (AVN) is a rare degenerative disease affecting 300,000–600,000 people annually. The femoral head is the most common site, accounting for 75% of cases. AVN can progress to joint destruction, often requiring surgical intervention. Risk factors include steroid use, diabetes, alcoholism, and decompression sickness. The Steinberg classification is used to grade AVN severity.

Methods

A retrospective chart review was conducted at Fremantle and Fiona Stanley Hospitals from 1989 to 2014. Patients treated with at least 20 sessions of hyperbaric oxygen therapy (HBOT) for AVN were included.

Primary outcome

Changes in MRI results; secondary outcomes: subjective improvement and need for surgery.

Results

21 joints in 14 patients were treated; 14 femoral heads and 7 femoral condyles. 64% of femoral head joints showed stable or improved MRI scans post-treatment. 71% reported good subjective outcomes; 3 joints required surgical intervention. In the femoral condyle group, all joints had stable or improved MRI scans, with no surgeries required.

Discussion

AVN significantly impacts quality of life and is increasingly prevalent due to rising diabetes rates. HBOT may reduce edema and restore blood flow, potentially preventing disease progression. The study's results align with previous research, showing similar effectiveness of HBOT in treating AVN.

Conclusions

HBOT may prevent disease progression in femoral AVN, with results comparable to other studies. The study supports the role of HBOT in treating femoral AVN, showing both radiological and subjective improvements.

Hyperbaric oxygen therapy for the treatment of Steinberg I and II avascular necrosis of the femoral head: a report of fifteen cases and literature review

Overview

This document reports on the effectiveness of hyperbaric oxygen therapy for treating avascular necrosis of the femoral head.

Abstract

The study involved 15 patients with Steinberg I-II avascular necrosis of the femoral head. Average follow-up was 22 months, with 13 patients showing satisfactory outcomes. Pain scores improved significantly (P<0.001), and 26.7% of hips progressed to collapse. No complications were reported, indicating safety and effectiveness of hyperbaric oxygen therapy.

Introduction

Avascular necrosis (AVN) can lead to debilitating conditions and major surgeries. Early intervention is crucial to prevent joint arthroplasty.
Hyperbaric oxygen (HBO) therapy is a less invasive alternative that improves microcirculation and reduces bone edema.

Materials and Methods

Data collected from a registry of patients treated between January 2010 and December 2018.

Inclusion Criteria

Adults with non-traumatic Steinberg stage I-II AVN confirmed by MRI.
Patients received 25-40 sessions of HBO therapy, with clinical evaluations conducted at regular intervals.

Results

15 patients (17 hips) treated; mean age was 36 years, with 47% females.
73.3% were Steinberg stage II; 86.7% had satisfactory outcomes with an average Oxford hip score of 37.3. Pain scores decreased from 5.1 to 1.5 (P<0.001), with no complications reported.

Discussion

HBO therapy showed a high rate of satisfactory outcomes (P=0.001).
26.7% of cases progressed to collapse, but all had satisfactory outcomes at follow-up. More high-level studies are needed to validate HBO's effectiveness in AVN treatment.

Clinical Outcome

Previous studies reported significant improvements in pain scores and hip range of motion with HBO therapy. Comparisons with untreated groups showed HBO significantly reduced the likelihood of lesion progression.

Radiological Outcome

Studies indicated that HBO therapy can lead to stable disease and radiographic improvement over time. Higher effectiveness noted in earlier stages of AVN.

Molecular Biology

HBO therapy influences the OPG/RANKL system, which is crucial in bone metabolism. Significant increases in soluble OPG were observed after HBO treatment.

Conclusion

HBO is a safe and effective treatment for pre-collapse AVN of the femoral head, with low rates of progression to collapse. Further validation through larger-scale trials is necessary.

HBOT References
Memar MY, Yekani M, Alizadeh N, Baghi HB.Hyperbaric oxygen therapy:
Antimicrobial Mechanisms and Clinical Application for Infections
Moghadam N, Hieda M, Ramey L, Levine BD, Guilliod R.
Hyperbaric Oxygen Therapy in Sports Musculoskeletal Injuries.
Hadanny A, Rittblat M, Bitterman M, May-Raz I, Suzin G, Boussi-Gross R, Zemel Y, Bechor Y, Catalogna M, Efrati S.
Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients – a retrospective analysis.
Zilberman-Itskovich S, Catalogna M, Sasson E, Elman-Shina K, Hadanny A, Lang E, Finci S,Polak N, Fishlev G, Korin C, Shorer R,
Parag Y, Sova M, Efrati S.
Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.
P, Shapira E, Landau G, Gattegno H, Zrachya A, Daniel-Kotovsky M, Catalogna M, Fishlev G, Lang E, Polak N, Doenyas K, Friedman M, Zemel Y, Bechor Y, Efrati S.
The effect of hyperbaric oxygen therapy on the pathophysiology of skin aging: a prospective clinical trial.
All Resources on HBOT
Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post‑COVID condition: randomized controlled trialHyperbaric Oxygen Therapy in Managing Minimally Invasive Aesthetic Procedure Complications: A Report of Three CasesHyperbaric Oxygen Therapy in Sports Musculoskeletal InjuriesA General Overview on the Hyperbaric Oxygen Therapy: Applications, Mechanisms and Translational OpportunitiesPost-COVID-19 fatigue: A systematic reviewTherapeutic Effects of Hyperbaric Oxygen: Integrated ReviewTranscutaneous oxygen tension-guided hyperbaric oxygen therapy for preventing skin necrosis after hyaluronic acid filler injectionsHyperbaric Oxygen – Its Mechanisms and EfficacyHyperbaric Oxygen Therapy: Future Prospects in Regenerative Therapy and Anti-AgingHyperbaric Oxygen Treatment: Effects on Mitochondrial Function and Oxidative StressHyperbaric Oxygen Therapy: Antimicrobial Mechanisms and Clinical Application for InfectionsEffects of Hyperbaric Oxygen Therapy on Long COVID : A Systematic ReviewEffects of Hyperbaric Oxygen Therapy on Inflammation, Oxidative/Antioxidant Balance, and Muscle Damage after Acute Exercise in Normobaric, Normoxic and Hypobaric, Hypoxic  Environments: A Pilot StudyHyperbaric Oxygen Therapy to Reverse Skin Aging
Conditions that benefits from HBOT
  • Depression
  • Diabetes
  • Musculoskeletal injuries
  • Sports injuries
  • Insomnia
  • Non healing ulcers
  • Post COVID19 symptoms
  • Post stroke cognitive recovery
  • Eczema
  • Chronic headache

At The Artisan Clinic, all our doctors are well-trained professionals.

PicoSure Pro is the latest reiteration of the original pico laser – it possesses settings much higher in power, so treatment must be administered by an experienced doctor.

Our Medical Director, Dr. Isaac Wong is an international trainer, and is often invited to speak in international conferences.

Dr Wong is an international trainer for CynoSure. He was recently selected to launch PicoSure Pro for Australia and at the upcoming AMWC Monaco Conference.

Enhancing Angiogenesis

HBOT supports the formation of new blood vessels

Reducing Inflammation

It regulates the number and activity of various inflammatory cell types

Enhancing Antioxidant Defenses

HBOT helps balance free radicals and scavengers

Counteracting Cellular Senescence

It may inhibit telomere shortening, a significant trigger for cellular aging

Static and dynamic content editing
Frequently asked questions

6 Reasons Why Top Athletes Use Hyperbaric Oxygen Therapy (HBOT)

Hyperbaric Oxygen Therapy (HBOT) is becoming increasingly popular among elite athletes for its ability to accelerate recovery, enhance performance, reduce inflammation, and improve cognitive function. By increasing oxygen levels in the body, HBOT helps optimize athletic performance and fast-tracks the natural healing processes following injury or intense physical activity.Hyperbaric Oxygen Therapy (HBOT) involves breathing pure oxygen in a pressurized chamber. While it has been used for years to treat various medical conditions, such as decompression sickness, carbon monoxide poisoning, and non-healing wounds, it has recently gained traction as a performance-enhancing treatment for athletes.

Athletes like NFL quarterback Tom Brady, NBA star LeBron James, and MMA champion Georges St-Pierre have all reported using HBOT to improve recovery and boost performance. The HMS team regularly treats professional athletes (across MLB, NFL, NBA, NHL, and ATP) and fitness enthusiasts with customized protocols to optimize muscle recovery and performance.So, why are top athletes incorporating HBOT into their routines, and what does the science say about its benefits?

Read more

Aging is inevitable but you can choose to age gracefully.

Naturally healthy skin

Rid your skin problems, wake up to beautiful clear skin.

Enhance facial contours

Get features you want with injectables that looks natural.

Thicker, fuller hair

Counter hair loss medically with our doctor-designed treatments.

Restore youthful looks

Reduce your skin age appearance by years.

Fair and dewy skin

Say hello to skin that looks like you have make up on.

Body slimming

Using FDA-approved machines to help you slim down faster.

About our founder

01
Founder / Medical Director of The Artisan Clinic
02
Ellanse Asia Advisory Board Member.
03
Winner of Ellanse / Silhouette Soft Combination Therapy Before After Competition in Barcelona 2018.
04
Accredited trainer for Dysport , Radiesse, Belotero.
05
International Trainer / Speaker for CynoSure Medical Devices, Ellanse , Silhouette Soft , Teoxane , Mint Lift.
06
International Speaker for Anti-Aging Medicine World Congress, Aesthetic Multi-Specialty, Euromedicom conferences.
View full profile

Let us transform you.

Recapture your beauty and witness the power of transformation at The Artisan Clinic. What are you struggling with now?

Please indicate your current problem or share any other remarks for us to note before your appointment.

Let's start your journey of transformation.

Your submission has been received.
Your submission has been received. Our customer representative will contact you soon! For quicker response, please call us at +65 8879 7887
Oops! Something went wrong while submitting the form.